Thalia Anastassaki

Title: Thalia Anastassaki: Innovator in Pharmaceutical Formulations

Introduction

Thalia Anastassaki is a prominent inventor based in Maroussi, Greece. She has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of tumors and leukemias. With a total of two patents to her name, her work showcases innovative approaches to cancer treatment.

Latest Patents

Anastassaki's latest patents focus on novel compositions that utilize labdanes for therapeutic purposes. These compositions are based on hydrated lipidic lamellar phases or liposomal formulations, which are created by combining various lipid molecules from both synthetic and natural sources. The key components of her inventions include labd-13-ene-8α, 15-diol and its derivatives, labd-14-ene-8, 13-diol or its derivatives, and 3β-hydroxy-labd-14-ene-8, 13-epoxy along with plant extracts containing these labdanes. The compositions have demonstrated cytotoxicity against cancerous cells, making them valuable for treating tumors and leukemias.

Career Highlights

Throughout her career, Thalia Anastassaki has worked with notable companies such as P.N. Gerolymatos S.A. and Medexis S.A. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Anastassaki has collaborated with several professionals in her field, including Demetra Angelopoulou and Demetrios Kokkinopoulos. These collaborations have further enriched her research and development efforts.

Conclusion

Thalia Anastassaki stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of cancer treatment. Her innovative formulations and collaborative efforts highlight her commitment to advancing medical science.